United States · FDA National Drug Code directory

Mavenclad

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44087-4000_c9ed888a-183b-45e9-9274-08aad408e926
Product NDC
44087-4000
Form
TABLET
Composition / generic term
Cladribine
Labeler
EMD Serono, Inc.
Marketing category
NDA
Marketing start / end (source format)
20190401
Source listing expiry
20271231

Source-listed ingredients

  • CLADRIBINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 BLISTER PACK in 1 CARTON (44087-4000-0) / 2 TABLET in 1 BLISTER PACK · 44087-4000-0
  • 4 BLISTER PACK in 1 CARTON (44087-4000-4) / 1 TABLET in 1 BLISTER PACK · 44087-4000-4
  • 5 BLISTER PACK in 1 CARTON (44087-4000-5) / 1 TABLET in 1 BLISTER PACK · 44087-4000-5
  • 6 BLISTER PACK in 1 CARTON (44087-4000-6) / 1 TABLET in 1 BLISTER PACK · 44087-4000-6
  • 7 BLISTER PACK in 1 CARTON (44087-4000-7) / 1 TABLET in 1 BLISTER PACK · 44087-4000-7
  • 8 BLISTER PACK in 1 CARTON (44087-4000-8) / 1 TABLET in 1 BLISTER PACK · 44087-4000-8
  • 9 BLISTER PACK in 1 CARTON (44087-4000-9) / 1 TABLET in 1 BLISTER PACK · 44087-4000-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →